Monoclonal antibodies against c-Met

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9068011
APP PUB NO 20130216548A1
SERIAL NO

13583743

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENMAB A/SCARL JACOBSENS VEJ 30 VALBY 2500

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Goeij Bart Maarssen, NL 32 453
Hoet, Rene Boxmeer, NL 40 582
Labrijn, Aran Frank Nigtevecht, NL 64 1182
Neijssen, Joost J Werkhoven, NL 30 647
Parren, Paul Odijk, NL 234 3032
Schuurman, Janine Diemen, NL 116 1580
Van, De Winkel Jan Zeist, NL 86 1568
Van, Den Brink Edward Norbert Halfweg, NL 29 577

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00